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Summary
 Aim Hemangiopericytomas (HP) are rare perivascular neoplasms with variable biolog-
ical behaviour. The prognosis, by histology alone, is diffi cult. The clinical course 
of disease and the localization of the tumour are of importance. Sinonasal HP is 
usually of low malignant potential. Currently, a less invasive, endonasal, approach 
is chosen for resection of such tumours. One case of sinonasal HP treated by en-
donasal surgery is presented.
 Case A 61-year old man presented with nasal obstruction and stated that he had under-
gone endonasal surgery elsewhere twice before for “nasal polyps”, 19 and eight 
years previously. Anterior rhinoscopy revealed a polypoid lesion in the right na-
sal cavity. CT showed a mass of the right ethmoidal and sphenoidal sinus with no 
sign of bone destruction. We performed an endonasal total resection of the tu-
mour. The histological diagnosis was of sinonasal HP. There was no local or re-
mote metastasis. Histological reports of the earlier surgeries were compared and 
identifi ed the same tumour.
 Conclusions The presented case shows a long-term benign course of recurrent sinonasal HP 
following endonasal resection. After more invasive approaches, such as lateral 
rhinotomy, local recurrence has been reported to appear within comparable pe-
riods of time. If the tumour is of limited extension, without infi ltration of neigh-
bouring structures, it can be removed via an endonasal approach.
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BACKGROUND
Hemangiopericytomas (HP) are rare perivascu-
lar tumours representing approximately one per 
cent of all vascular neoplasms [1]. First described 
by Stout and Murray in 1942, they are thought 
to derive from pericytes [2]. Microscopically, 
HP is characterized by a proliferation of spin-
dle-shaped to ovoid cells between vascular chan-
nels. Immunohistochemically, cases of sinona-
sal HP express mostly vimentin and factor XIIIa 
[3]. HP can occur throughout the body, though 
less than one third are found in the head and 
neck region [4]. The prediction of biological 
behaviour by histopathological criteria is diffi -
cult, while the clinical course and the localiza-
tion of the tumour are also of importance. In 
comparison with other localizations, sinonasal 
HP is usually of low malignant potential [5]. 
The treatment of choice is wide surgical exci-
sion, via lateral rhinotomy or the Caldwell-Luc 
approach, for example. Recently, endonasal re-
moval has been selected as a less invasive tumour 
resection method [6,7].
AIM
We present one case of sinonasal HP treated by 
endonasal surgery.
CASE REPORT
A 61-year old male patient attended the clinic 
complaining of a slowly progressive nasal obstruc-
tion on the right side for six months. The patient 
stated that he had undergone endonasal surgery 
elsewhere because of “nasal polyps” 19 and eight 
years previously. No epistaxis was noted. Nasal ex-
amination revealed the presence of a polypoid 
structure in the right nasal cavity. A CT scan con-
fi rmed the involvement of the right ethmoid and 
sphenoid sinuses, with no sign of bone destruc-
tion (Figure 1). Cerebral infi ltration was ruled out 
by MRI. An endonasal microscopic/endoscopic 
tumour resection was performed. The polypoid 
neoplasm was removed completely. No postop-
erative complications were noted. The histopa-
thology report was of sinonasal HP (Figure 2). 
Immunohistochemically, the tumour was positive 
for vimentin and actin (Figure 3). Three per cent 
of the nuclei showed positive staining with Ki-67 
indicating low proliferative activity. There were 
no metastases to the lung, the liver, the cervical 
lymph nodes or to the bones. The histologies of 
the former surgeries were revised. In both cases 
the same tumour was identifi ed.
DISCUSSION
Despite the fi rst description of sinonasal HP be-
ing made in 1942, endonasal tumour resection, 
Figure 1. CT scan of the paranasal sinuses. The neoplasm fi lls the 
right ethmoid and sphenoid sinuses, with no sign of bone erosion.
Figure 2. The histological appearance of sinonasal heman-
giopericytoma. (Hematoxylin and eosin stain).
Figure 3. Immunohistochemistry showing expression of vimentin .
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as a less invasive approach, has only recently been 
proposed [6–8]. In the case presented, eleven 
years after fi rst endonasal surgery and again 
eight years later the patient underwent surgery 
for local tumour recurrence. It has been report-
ed that, after more invasive approaches such as 
lateral rhinotomy, local recurrence can appear 
in comparable periods of time [9]. According 
to Marianowski et al., the local recurrence rate 
of sinonasal HP ranges from eight to 53 per 
cent [10].
Few authors have described cases of malignant 
sinonasal HP [11,12]. A mostly benign course 
has been reported [5,13–15]. The usual his-
tological criteria for tumour malignancy are 
less predictive with respect to the behaviour 
of sinonasal HP [16]. Kowalski et al. suggest-
ed that the proliferation index, measured by 
using an immunoperoxidase stain for Ki-67, 
of ten per cent or higher may indicate a more 
agressive subset of HP [17]. The tumour of our 
patient showed a proliferation index of only 
three per cent.
Nasal obstruction and epistaxis are the most fre-
quent symptoms of sinonasal HP. Macroscopically, 
it appears as a reddish-grey polypoid mass which 
bleeds easily on biopsy or manipulation and may 
mimic allergic polyps [13]. Examination should 
include axial and coronal contrast CT scans. MRI 
scans are helpful in determining whether or not 
intracranial extension is present. Preoperative 
angiography and embolization can facilitate sur-
gical tumour resection [18]. Care must be taken 
with differential diagnosis between sinonasal HP 
and other soft tissue tumours such as glomus tu-
mours or vascular leiomyoma [19].
Radiotherapy is used in cases of non-radical sur-
gical resection, for inoperable tumours or metas-
tases [20]. Few reports of successful combination 
chemotherapy in patients with metastatic disease 
have been published [21].
Compagno and Hyams proposed to distinguish 
non-aggressive “HP-like tumours” of the nasal cav-
ity from soft tissue HP [13]. This new entity is 
the subject of controversy among authors [9,12]. 
Microscopically, these “HP-like tumours” should 
show a vascular architecture with ovoid to spin-
dle-shaped cells in a more orderly distibution, 
without nuclear or cytoplasmic pleomorphism, 
mitotic activity or necrosis. In the case presented 
here, the neoplasm could be histologically clas-
sifi ed as a “HP-like tumour”.
CONCLUSIONS
The presented case is an example of a benign, 
long-term course of recurrent sinonasal HP fol-
lowing endonasal resection. If such tumours are 
of limited extension without infi ltration into 
neighbouring structures they may be removed 
by application of an endonasal approach. Very 
late recurrences and metastases are possible, life-
long follow-up is recommended [12].
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